Literature DB >> 20658731

Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients.

I Zelen1, P Djurdjevic, S Popovic, M Stojanovic, V Jakovljevic, S Radivojevic, D Baskic, N Arsenijevic.   

Abstract

PURPOSE: Overproduction of reactive oxygen species (ROS) intermediates above the functional capability of cellular antioxidants may result in instability of important macromolecules and represents the molecular basis of many diseases including inflammation processes, cardiovascular alterations, cancer etc. The purpose of this study was to determine plasma level of superoxide anion, hydrogen-peroxide and malondialdehyde (MDA) as markers of oxidative stress and activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) as antioxidant enzymes in B-chronic lymphocytic leukemia (B-CLL) patients.
METHODS: The study included 29 untreated B-CLL patients in stage A, and 21 in stages B and C, classified according to the Binet system; 31 healthy volunteers formed the control group. After centrifugation of heparinized peripheral blood, plasma levels of all investigated parameters were determined using spectrophotometric methods.
RESULTS: Plasma CAT activity was increased in B-CLL patients compared with control subjects; also, progression of disease was related with significantly higher plasma activity of CAT. Also, B-CLL patients showed significantly higher plasma concentration of MDA compared with controls. No statistically significant differences of superoxide anion and hydrogen peroxide as well as plasma activity of SOD and GPx between the tested groups were noted.
CONCLUSION: Increase of CAT activity in B-CLL patients indicates that there is stimulation of the antioxidant enzyme system, while the increase of MDA concentration shows increased lipid peroxidation level. According to these results it could be concluded that an imbalance exists between oxidants and antioxidants in the plasma of B-CLL patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658731

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  13 in total

1.  B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.

Authors:  Christopher S Wilson; Jason M Spaeth; Jay Karp; Blair T Stocks; Emilee M Hoopes; Roland W Stein; Daniel J Moore
Journal:  JCI Insight       Date:  2019-04-09

2.  Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity.

Authors:  Mirjana Veselinovic; Nevena Barudzic; Milena Vuletic; Vladimir Zivkovic; Aleksandra Tomic-Lucic; Dragan Djuric; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2014-03-09       Impact factor: 3.396

Review 3.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

4.  The role of oxidative stress and the effects of antioxidants on the incidence of infectious complications of chronic lymphocytic leukemia.

Authors:  Amelia Maria Gaman; Ana-Maria Buga; Mihnea-Alexandru Gaman; Aurel Popa-Wagner
Journal:  Oxid Med Cell Longev       Date:  2014-10-14       Impact factor: 6.543

5.  Antioxidant Activities of Basella alba Aqueous Leave Extract In Blood, Pancreas, and Gonadal Tissues of Diabetic Male Wistar Rats.

Authors:  Dennis Seyi Arokoyo; Ibukun Peter Oyeyipo; Stefan Simon Du Plessis; Yapo Guillaume Aboua
Journal:  Pharmacognosy Res       Date:  2018 Jan-Mar

6.  Antidiabetic, Lipid Normalizing, and Nephroprotective Actions of the Strawberry: A Potent Supplementary Fruit.

Authors:  Pallavi Mandave; Suresh Khadke; Manjiri Karandikar; Vijaya Pandit; Prabhakar Ranjekar; Aniket Kuvalekar; Nitin Mantri
Journal:  Int J Mol Sci       Date:  2017-01-11       Impact factor: 5.923

Review 7.  The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.

Authors:  Mads Emil Bjørn; Hans Carl Hasselbalch
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

8.  The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.

Authors:  Kim R Kampen; Sergey O Sulima; Benno Verbelen; Tiziana Girardi; Stijn Vereecke; Gianmarco Rinaldi; Jelle Verbeeck; Joyce Op de Beeck; Anne Uyttebroeck; Jules P P Meijerink; Anthony V Moorman; Christine J Harrison; Pieter Spincemaille; Jan Cools; David Cassiman; Sarah-Maria Fendt; Pieter Vermeersch; Kim De Keersmaecker
Journal:  Leukemia       Date:  2018-06-21       Impact factor: 11.528

Review 9.  Casein and Peptides Derived from Casein as Antileukaemic Agents.

Authors:  Edgar Ledesma-Martínez; Itzen Aguíñiga-Sánchez; Benny Weiss-Steider; Ana Rocío Rivera-Martínez; Edelmiro Santiago-Osorio
Journal:  J Oncol       Date:  2019-09-08       Impact factor: 4.375

10.  Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.

Authors:  Walaa Darwiche; Cathy Gomila; Hakim Ouled-Haddou; Marie Naudot; Cécile Doualle; Pierre Morel; Florence Nguyen-Khac; Loïc Garçon; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  J Exp Clin Cancer Res       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.